<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-903-SII-32785</iati-identifier>
  <reporting-org ref="XM-DAC-903" type="40">
   <narrative xml:lang="EN">International Finance Corporation</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Labnet CIS Project</narrative>
  </title>
  <description type="2">
   <narrative xml:lang="EN">(i) Contribute to improved healthcare standards for quality, efficiency and ethical practices in acquired regional units.  (ii) Expand access of middle and/or low-income patients to modern diagnostic services.  (iii) South - South Investment, a priority for IFC since such investments are thought to promote&#xC2;&#xA0;increased regional integration and creation of regional champions.  (iv) Direct job creation: The Company will create approximately 800 new jobs by 2018, of which 40% are medical personnel (nurses and medical technicians) and approxmately 65% are female.</narrative>
  </description>
  <description type="1">
   <narrative xml:lang="EN">The Company is undertaking $17 million investment program to: i) execute acquisition of labs across Southern Russia and Ukraine; and ii) finance organic growth of new collection centers as part of its blueprint growth framework in order to increase test volumes and improve the overall quality provision across its operating subsidiaries.</narrative>
  </description>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">MedLab Co&#xF6;peratief U.A.</narrative>
  </participating-org>
  <participating-org activity-id="XM-DAC-903-SII-32785" ref="XM-DAC-903" role="1" type="40"></participating-org>
  <activity-status code="6"></activity-status>
  <activity-date iso-date="2014-07-08" type="1"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">International Finance Corporation</narrative>
   </organisation>
   <telephone>+12024733800</telephone>
   <email>ccspg@ifc.org</email>
   <website>www.ifc.org</website>
   <mailing-address>
    <narrative xml:lang="EN">2121 Pennsylvania Avenue, NW Washington DC 20433</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN">123, Karasai Batir street, Almaty, Kazakhstan  Tel:: +7 (727) 258 83 83Fax: +7 (727) 399 87 72</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN">Mr. Almaz Bazarbaev, Chief Operating Officer, 123, Karasai Batir street, Almaty, Kazakhstan  Tel:: +7 (727) 258 83 83Fax: +7 (727) 399 87 72</narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="XX" percentage="100">
   <narrative xml:lang="EN">Central Asia Region</narrative>
  </recipient-country>
  <location ref="XX-Central Asia Region">
   <location-reach code="1"></location-reach>
   <location-id code="1453782" vocabulary="G1"></location-id>
   <name>
    <narrative xml:lang="EN">The Project is to be mainly invested in the three regions of Russian Federation (Volga, Urals and Siberia), as well as Ukraine. Investments will mainly comprise acquisition finance, as well as funding of operational companies organic growth in all four countries of operation.</narrative>
   </name>
   <description>
    <narrative xml:lang="EN">Location description</narrative>
   </description>
   <activity-description>
    <narrative xml:lang="EN">A description that qualifies the activity taking place at the location.</narrative>
   </activity-description>
   <administrative code="1453782" level="1" vocabulary="G1"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>43.0046500000 71.7187500000</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="1"></location-class>
   <feature-designation code="ADMF"></feature-designation>
  </location>
  <sector percentage="100" vocabulary="11" vocabulary-uri="http://www.census.gov/cgi-bin/sssd/naics/naicsrch?chart=2012">
   <narrative xml:lang="EN">S-AB - Medical Laboratories</narrative>
  </sector>
  <country-budget-items vocabulary="1">
   <budget-item code="7.2.1" percentage="100" vocabulary="1">
    <description>
     <narrative xml:lang="EN">Total: $12.50 million</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="6"></collaboration-type>
  <default-flow-type code="35"></default-flow-type>
  <default-finance-type code="510"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <document-link format="TEXT/HTML" url="https://disclosures.ifc.org/#/projectDetail/SII/32785">
   <title>
    <narrative xml:lang="EN">Summary of Investment Information - Anticipated Impact Measurement &amp; Monitoring (AIMM) Assessment and Main Environmental &amp; Social Risks and Impacts of the Project</narrative>
   </title>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://disclosures.ifc.org/#/projectDetail/SII/32785">
   <title>
    <narrative xml:lang="EN">Summary of Investment Information</narrative>
   </title>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
 </iati-activity>
</iati-activities>
